NO872675L - Middel for hemning av avstoetning av transplanterte organer - Google Patents

Middel for hemning av avstoetning av transplanterte organer

Info

Publication number: NO872675L
Authority: NO; Norway
Prior art keywords: heparin; disposal; inhibiting; humans; transplanted organs
Prior art date: 1986-06-26

Application number

NO872675A

Other languages

English (en)

Norwegian (no)

Other versions

NO872675D0 (no

Inventor

Irun Cohen

Israel Vlodavsky

Amiram Eldor

Yaakov Naparstek

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-26

Filing date

1987-06-25

Publication date

1987-12-28

1987-06-25 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

1987-06-25 Publication of NO872675D0 publication Critical patent/NO872675D0/no

1987-12-28 Publication of NO872675L publication Critical patent/NO872675L/no

Links

230000002401 inhibitory effect Effects 0.000 title 1
210000000056 organ Anatomy 0.000 title 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 3
229960002897 heparin Drugs 0.000 abstract 2
229920000669 heparin Polymers 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
230000002429 anti-coagulating effect Effects 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Materials For Medical Uses (AREA)
Soil Working Implements (AREA)
Paper (AREA)
Fertilizers (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO872675A 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer NO872675L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL79254A IL79254A0 (en)	1986-06-26	1986-06-26	Compositions for preventing graft rejection

Publications (2)

Publication Number	Publication Date
NO872675D0 NO872675D0 (no)	1987-06-25
NO872675L true NO872675L (no)	1987-12-28

Family

ID=11056896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO872675A NO872675L (no)	1986-06-26	1987-06-25	Middel for hemning av avstoetning av transplanterte organer

Country Status (10)

Country	Link
EP (1)	EP0251134B1 (fr)
JP (1)	JP2527749B2 (fr)
AT (1)	ATE82502T1 (fr)
AU (1)	AU608228B2 (fr)
DE (1)	DE3782686T2 (fr)
DK (1)	DK169422B1 (fr)
ES (1)	ES2052514T3 (fr)
GR (1)	GR3006814T3 (fr)
IL (1)	IL79254A0 (fr)
NO (1)	NO872675L (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5541166A (en) *	1987-01-23	1996-07-30	The Australian National University	Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) *	1987-01-23	1994-08-26	Univ Australian	Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
GB8808810D0 (en) *	1988-04-14	1988-05-18	Biopharm Clinical Research Ltd	Heparin-containing formulations
IL86753A0 (en) *	1988-06-15	1988-11-30	Hadassah Med Org	Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) *	1988-06-23	1989-12-28	Solco Basel Ag	Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) *	1988-12-01	1989-07-31	Hadassah Med Org	Compositions containing a compound binding to a heparin receptor
US5158940A (en) *	1990-02-14	1992-10-27	The United States Government As Represented By The Secretary, Dhhs	Use of suramin to treat rheumatologic diseases
WO1999003493A1 (fr) *	1997-07-14	1999-01-28	Meiji Milk Products Co., Ltd.	Medicaments contenant midkine en tant principe actif ou inhibiteurs desdits medicaments
US6538028B1 (en)	2000-02-01	2003-03-25	Vanderbilt University	Method for inhibiting complement activation
CN1197587C (zh) *	2000-06-09	2005-04-20	中国科学院上海细胞生物学研究所	N－位脱硫酸肝素在预防和治疗炎症中的应用
CZ307433B6 (cs)	2001-09-12	2018-08-22	Leadiant Biosciences Sa	Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
ES2399277T3 (es)	2004-05-27	2013-03-27	Baxter International Inc.	Procedimiento de tratamiento de trastornos hemorrágicos utilizando polisacáridos sulfatados
WO2010020423A2 (fr)	2008-08-22	2010-02-25	Baxter Healthcare S.A.	Méthodes de traitement de troubles du saignement
JP6393453B2 (ja)	2010-01-14	2018-09-19	バクスアルタゲーエムベーハー	出血性障害を治療するための方法及び組成物
EP2734213B1 (fr)	2011-07-19	2018-06-06	Baxalta GmbH	Activateurs de résorption comme additifs pour améliorer la formulation orale de polysaccharides sulfatés non anticoagulants
EP2885642B1 (fr)	2012-08-14	2019-05-15	Baxalta GmbH	Procédés et systèmes de criblage de compositions comprenant des polysaccharides sulfatés non coagulants
EP3578184A1 (fr)	2013-03-12	2019-12-11	Baxalta GmbH	Activateurs de résorption utilisés comme additifs pour améliorer la formulation orale d'héparines à faible poids moléculaire
SE538503C2 (en)	2014-11-11	2016-08-16	Tx Medic Ab	New dextran sulfate
WO2016198578A1 (fr) *	2015-06-11	2016-12-15	Universiteit Maastricht	Procédé de prévention d'échec de greffe chez un hôte
JP2025516366A (ja) *	2022-05-06	2025-05-27	バージェントセラピューティクスプロプライエタリーリミテッド	同種移植拒絶反応の治療方法

1986
- 1986-06-26 IL IL79254A patent/IL79254A0/xx unknown
1987
- 1987-06-23 EP EP87108976A patent/EP0251134B1/fr not_active Expired - Lifetime
- 1987-06-23 AT AT87108976T patent/ATE82502T1/de not_active IP Right Cessation
- 1987-06-23 ES ES87108976T patent/ES2052514T3/es not_active Expired - Lifetime
- 1987-06-23 DE DE8787108976T patent/DE3782686T2/de not_active Expired - Fee Related
- 1987-06-25 AU AU74706/87A patent/AU608228B2/en not_active Ceased
- 1987-06-25 NO NO872675A patent/NO872675L/no unknown
- 1987-06-26 DK DK331287A patent/DK169422B1/da not_active IP Right Cessation
- 1987-06-26 JP JP62159514A patent/JP2527749B2/ja not_active Expired - Lifetime
1993
- 1993-01-14 GR GR930400069T patent/GR3006814T3/el unknown

Also Published As

Publication number	Publication date
DE3782686T2 (de)	1993-06-09
ES2052514T3 (es)	1994-07-16
NO872675D0 (no)	1987-06-25
JPS6388127A (ja)	1988-04-19
JP2527749B2 (ja)	1996-08-28
AU608228B2 (en)	1991-03-28
DK169422B1 (da)	1994-10-31
GR3006814T3 (fr)	1993-06-30
IL79254A0 (en)	1986-09-30
DK331287A (da)	1987-12-27
EP0251134A2 (fr)	1988-01-07
DE3782686D1 (de)	1992-12-24
AU7470687A (en)	1988-01-07
EP0251134A3 (en)	1989-05-03
DK331287D0 (da)	1987-06-26
ATE82502T1 (de)	1992-12-15
EP0251134B1 (fr)	1992-11-19

Similar Documents

Publication	Publication Date	Title
NO872675D0 (no)	1987-06-25	Middel for hemning av avstoetning av transplanterte organer
EP0184040A3 (en)	1988-03-09	Method and system for removing immunosuppressive components from the blood of mammals
ATE190496T1 (de)	2000-04-15	Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
ES2137225T3 (es)	1999-12-16	Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
ATE10340T1 (de)	1984-12-15	Stabilisierung der aktivitaet des faktors viii im blutplasma.
MX9101869A (es)	1993-04-01	Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
OA07116A (fr)	1984-03-31	Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
ATE135215T1 (de)	1996-03-15	Verwendung von rapamycin, dessen derivaten und prodrugs zur herstellung eines arzneimittels zur hemmung der transplantatabstossung bei säugetieren
DE69023957D1 (de)	1996-01-18	Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
DE69435303D1 (de)	2010-09-02	Er behandlung von krankheiten bei denen eine cytok
DE69132048D1 (de)	2000-04-20	Verwendung von Steroiden zur Inhibierung von Angiogenesis
ES2147780T3 (es)	2000-10-01	Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
EP0011651A4 (fr)	1980-05-21	Composition pharmaceutique contenant 3-oxo-2,3-dihydro-(1)-benzothiophène-2-spirocyclopropane te ce composé utilisable dans la prophylaxie ou le traitement des troubles cardio-vasculaires.
DE3584560D1 (de)	1991-12-05	Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE81467T1 (de)	1992-10-15	Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
EP0058397A3 (fr)	1984-01-04	Anticoagulant et son utilisation
ES2032192T3 (es)	1993-01-16	Composiciones elastomeras reticulables.
ATE113591T1 (de)	1994-11-15	4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
SE8802193L (sv)	1989-02-08	Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
BR8400127A (pt)	1984-08-21	Composicao para o combate de crescimento indesejado de plantas,processo para a obtencao de 3,4-di-(metilamino)-6-terc.-butil-4,5-dihidro-1,2,4-triazin-5-ona,processo para a obtencao de uma composicao utilizacao e processo para o combate de ervas daninhas
ES2062332T3 (es)	1994-12-16	Benzoxazolonas antiinflamatorias.
DE69022027D1 (de)	1995-10-05	2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
De Costa	1982	Severe poisoning by cholinesterase inhibition in Portugal.
DE68904195D1 (de)	1993-02-11	Paromomycin oder seine derivate zur parenteralen behandlung von parasitaeren erkrankungen beim menschen.